RHD Genotype Matched Red Cells for Anti-D

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 8, 2020

Primary Completion Date

March 4, 2024

Study Completion Date

October 4, 2024

Conditions
Sickle Cell DiseaseAnti-D Antibodies
Interventions
BIOLOGICAL

D+ RH genotype matched red cell units for transfusion

Chronically transfused patients with SCD and anti-D will receive D+ RH genotyped matched red cell units for transfusion in addition to standard C, E, and K antigen matching and being hemoglobin S negative, which is the Children's Hospital of Philadelphia institutional standard of care for patients with SCD. RH genotyping of donor units will be performed by the New York Blood Center (NYBC) Immunogenetics laboratory.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

New York Blood Center

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT04156906 - RHD Genotype Matched Red Cells for Anti-D | Biotech Hunter | Biotech Hunter